Baxter PrisMax - HSA Registration DE0503675
Access comprehensive regulatory information for Baxter PrisMax in the Singapore medical device market through Pure Global AI's free database. This CLASS C medical device is registered under HSA registration number DE0503675 and owned by Baxter Healthcare SA. The device was registered on October 01, 2019.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The PrisMax control unit is intended for : • Continuous Renal Replacement Therapy (CRRT) for patients with acute renal failure and/or fluid overload. • Therapeutic Plasma Exchange (TPE) therapy for patients with diseases where removal of plasma components is indicated. • Hemoperfusion (HP) for patients with conditions where immediate removal of substances by adsorption is indicated. • Extracorporeal CO2 Removal (ECCO2R) for patients with conditions where extracorporeal elimination of carbon dioxide is indicated (only applicable for PrisMax Control Unit software 3.0 or later).